Q2 2017 13F Holders as of 30 Jun 2017
-
Type / Class
-
Equity / S&P PHARMAC
-
Number of holders
-
77
-
Total 13F shares, excl. options
-
4,002,762
-
Shares change
-
-120,837
-
Total reported value, excl. options
-
$172,249,892
-
Value change
-
-$5,007,669
-
Number of buys
-
34
-
Number of sells
-
-35
-
Price
-
$43.03
Significant Holders of SPDR SERIES TRUST - S&P PHARMAC (XPH) as of Q2 2017
88 filings reported holding XPH - SPDR SERIES TRUST - S&P PHARMAC as of Q2 2017.
SPDR SERIES TRUST - S&P PHARMAC (XPH) has 77 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 4,002,762 shares
.
Largest 10 shareholders include GOLDMAN SACHS GROUP INC (908,348 shares), MORGAN STANLEY (618,005 shares), BANK OF AMERICA CORP /DE/ (505,747 shares), Psagot Investment House Ltd. (288,789 shares), UBS Group AG (243,351 shares), Wharton Business Group, LLC (221,160 shares), Baird Financial Group, Inc. (132,267 shares), BNP PARIBAS ARBITRAGE, SA (100,000 shares), IFP Advisors, Inc (83,206 shares), and Kranot Hishtalmut Le Morim Ve Gananot Havera Menahelet LTD (72,454 shares).
This table shows the top 77 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.